Skip to main
CTNM
CTNM logo

Contineum Therapeutics Inc (CTNM)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy CTNM Stock

About Contineum Therapeutics Inc (CTNM)

Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.
Market cap$134.01M
Yesterday's volume100
Revenue (TTM)
Avg. daily volume197.15K
EBITDA (TTM)-$58.8M
Open$5.70
Price / earnings ratio-2.68x
Yesterday's range$4.76 - $5.7
Debt / equity3.25x
52 week range$3.35 - $21.59
5 year debt / equity-141.41x
Beta (LTM)0.82x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio21.47x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

CTNM Stock Rating

What analysts recommend for CTNM stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 22, 2025, the market cap for CTNM stock is $134.02M

The current P/E ratio for CTNM stock is -2.68

The 52-week high for CTNM stock is $21.59. The current CTNM stock price $undefined is 100.00% below its 52-week high

The 52-week low for CTNM stock is $3.35. The current CTNM stock price $undefined has increased 100.00% from its 52-week low

No, the CTNM stock does not pay dividends to its shareholders

The target price for CTNM stock is $23.80 based on the average of what a group of analyst think CTNM stock could be worth at a future date. This is not a prediction by Public.com

How to buy CTNM stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CTNM stock

    Navigate to the Explore page. Then, type CTNM into the search bar. When you see CTNM stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CTNM stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Contineum Therapeutics Inc Stock Earnings

The value each CTNM share was expected to gain vs. the value that each CTNM share actually gained.

CTNM (CTNM) reported Q1 2025 earnings per share (EPS) of -$0.62, missing estimates of -$0.57 by 8.77%. In the same quarter last year, CTNM's earnings per share (EPS) was -$3.55. CTNM is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of -$0.47.

Buy CTNM Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.